ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Balance Sheet
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total assets for Q2 2025 were ¥771.24M, a decrease of -16.35% from the previous quarter. HK:1541 total liabilities were ¥237.36M for the fiscal quarter, a -2.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.